comparemela.com

Latest Breaking News On - Boehringer ingelheim gmbh - Page 5 : comparemela.com

Sanofi to Pay $100 Million to Settle Zantac Cancer Lawsuits

Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn users that its Zantac heartburn

United statesUnited kingdomFrance generalCity ofBoehringer ingelheim gmbAngela valadezPfizer incBoehringer ingelheim gmbh

Sanofi to pay US$100 million to settle Zantac cancer lawsuits

Sanofi to pay US$100 million to settle Zantac cancer lawsuits
businesstimes.com.sg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstimes.com.sg Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBoehringer ingelheim gmbAngela valadezBoehringer ingelheim gmbh

Consumer Healthcare Market, 33% of Growth to Originate from North America, Technavio

/PRNewswire/ The global consumer healthcare market size is estimated to grow by USD 189.13 bn from 2023 to 2027, according to Technavio. The market is.

United kingdomUnited statesBoehringer ingelheim gmbJesse maidaDigital healthResearch analysisTechnavio researchAbbott laboratoriesConsumer healthcare marketNorth americaBoehringer ingelheim gmbh

Sanofi to Settle About 4,000 Suits Over Zantac Cancer Claims

Sanofi SA said it has agreed to settle approximately 4,000 lawsuits accusing the French drugmaker of selling its Zantac heartburn medicine without warning

France generalUnited statesCity ofUnited kingdomVivian medinillaRobin rosenbergBoehringer ingelheim gmbEuropean medicines agencyDrug administrationInternational chamberPfizer incJudge robin rosenbergBoehringer ingelheim gmbh

Sanofi to settle about 4,000 suits over Zantac cancer claims

Sanofi SA said it has agreed to settle approximately 4,000 lawsuits accusing the French drugmaker of selling its Zantac heartburn medicine without warning patients that it could cause cancer. The pact, the first major resolution of cases related to the product, will apply to litigation pending in courts in states…

United statesCity ofUnited kingdomFrance generalVivian medinillaBoehringer ingelheim gmbRobin rosenbergPfizer incInternational chamberEuropean medicines agencyDrug administrationJudge robin rosenbergBoehringer ingelheim gmbh

vimarsana © 2020. All Rights Reserved.